Peter Greenleaf, Aurinia CEO

Af­ter pass­ing on Ac­celeron, Bris­tol My­ers eyes bolt-on ac­qui­si­tion of au­toim­mune spe­cial­ist — re­port

Bris­tol My­ers Squibb is look­ing to beef up its au­toim­mune port­fo­lio by scoop­ing up Au­rinia Phar­ma­ceu­ti­cals, Bloomberg re­port­ed.

The re­cent over­tures to Au­rinia, re­layed by …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.